Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin
Top Cited Papers
- 1 June 2003
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 3 (6), 589-601
- https://doi.org/10.1016/s1535-6108(03)00133-8
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Quantitative Trait Loci Influence Renal Disease Progression in a Mouse Model of Alport SyndromeThe American Journal of Pathology, 2002
- Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrinsNature Medicine, 2002
- The Hallmarks of CancerCell, 2000
- Differential distribution of type IV collagen chains in the developing rat testis and ovaryDifferentiation, 1998
- Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome.Genes & Development, 1996
- Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome.The Journal of cell biology, 1996
- COLLAGENS: Molecular Biology, Diseases, and Potentials for TherapyAnnual Review of Biochemistry, 1995
- Serum Levels of Laminin, Type IV Collagen and Type III Procollagen Peptide as Markers for Detection of MetastasisJapanese Journal of Cancer Research, 1994
- Assessment of disease activity in essential cryoglobulinemia by serum levels of a basement membrane antigen, lamininArthritis & Rheumatism, 1988